SH-114

N/A

Report date: 2023/08/17 17:51:18
NME

Base Information

Drug NameSH-114
Drug Alias NameSH-114
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShorla Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesShorla Oncology Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A